London-listed Instem has been taken private in a £200m deal marking the second British life sciences company this week to be snapped up as foreign buyers target the UK for cheap takeover deals.
The Staffordshire-based company, which provides IT services used in drug development for the global life sciences market, has been acquired by French healthcare-focused private equity group Archimed SAS for £203m.